Profile

Cover photo
Alan Kotok
Worked at Science magazine
Attended Boston University
Lives in Arlington, Va.
9,069 followers|1,349,806 views
AboutPostsVideos

Stream

Alan Kotok
moderator

Medicine  - 
 
A study by the Mayo Clinic finds people with a history of substance abuse and using tobacco are those most at risk for using opioid pain killers on a continuous basis. ‪#‎Science‬ ‪#‎Health‬
A Mayo Clinic study finds people with a history of substance abuse and using tobacco are those most at risk for using opioid pain killers on a continuous basis.
3
Zex Konjina's profile photoAlan Kotok's profile photo
2 comments
 
Actually +Zex Konjina it was done at little cost. The research team sampled deidentified medical records from the Rochester Epidemiology Project, and found patterns pain-killer prescribing that were not well documented before. 
Add a comment...

Alan Kotok

Engineering and Technology  - 
 
Aclima Inc., a designer of environmental monitoring sensors and networks, unveiled today collaborations with Google Inc., U.S. Environmental Protection Agency, and Lawrence Berkeley National Lab, among others. #Science #Engineering #Business
Aclima Inc., a designer of environmental monitoring sensors and networks, unveiled today collaborations with Google Inc., EPA, and Berkeley National Lab.
5
1
Jason Usborne's profile photo
Add a comment...

Alan Kotok
moderator

Immune System  - 
 
Biotechnology company Juno Therapeutics Inc. and biopharmaceutical developer Celgene Corp. are collaborating on therapies that harness the immune system to treat cancer and autoimmune diseases over the next 10 years. #Science #Business
Juno Therapeutics and Celgene are collaborating on therapies that harness the immune system to treat cancer and autoimmune diseases over the next 10 years.
5
1
Quantum Paradigm's profile photo
Add a comment...

Alan Kotok
moderator

Discussion  - 
 
Novartis is acquiring Spinifex Pharmaceuticals Inc., a developer of new types of therapies for neuropathic pain. Spinifex's technology targets angiotensin II receptors in the peripheral nervous system. #Science #Business
Global pharmaceutical company Novartis is acquiring Spinifex Pharmaceuticals Inc., a developer of new types of therapies for neuropathic pain.
6
Mesothelioma Circle's profile photoAlan Kotok's profile photoTre Jay's profile photo
3 comments
Tre Jay
 
Kauris AOL
Add a comment...

Alan Kotok

Shared publicly  - 
 
There seems to be a rainbow theme among many G+ posts today. This rainbow has nothing to do with same-sex relationships, but I'll probably never take another shot like this one ever again. I took the photo in Cienfuegos, Cuba in January 2013.
5
Joe Dunlavy's profile photodavid webber's profile photo
2 comments
 
Tropical humid air and sun great for rainbows.
Add a comment...

Alan Kotok
moderator

Infectious Diseases  - 
 
A commercial point-of-care test detecting Ebola virus in the blood of a patient was shown in a field test in Sierra Leone to be as accurate as tests sent to remote labs for analysis. #Science #Health #Business
A point-of-care test detecting Ebola virus in a patient was shown in a field test in Sierra Leone to be as accurate as tests sent to remote labs for analysis.
5
1
Leah Shell's profile photo
Add a comment...

Alan Kotok
moderator

Neuroscience  - 
 
ALS Association is funding pilot studies with patients having amyotrophic lateral sclerosis to confirm biomarkers, or biochemical indicators, that improve responsiveness to therapies. #Science #Business  
ALS Association funding studies with patients having amyotrophic lateral sclerosis to confirm biomarkers that improve responsiveness to therapies.
5
Add a comment...
 
Biotechnology company Juno Therapeutics and biopharmaceutical developer Celgene Corp. are collaborating on therapies that harness the immune system to treat cancer and autoimmune diseases over the next 10 years. #Science #Business
Juno Therapeutics and Celgene are collaborating on therapies that harness the immune system to treat cancer and autoimmune diseases over the next 10 years.
2
Add a comment...

Alan Kotok
moderator

Genomics  - 
 
A registry of families with individuals having Sjögren-Larsson syndrome aims to systematically collect data about families’ experiences with the disease and provide a source of participants for clinical trials of therapies. #Science #Business
A registry of families with Sjögren-Larsson syndrome is being formed to collect data on experiences with the disease and provide participants for drug trials.
8
1
Dr Raj Patel's profile photo
Add a comment...

Alan Kotok

Shared publicly  - 
 
For #ScienceSunday  we report on a clinical trial testing a synthesized therapy for sickle cell disease that began enrolling participants this week. Te drug, called Rivipansel, is designed to improve blood cell flow of people with sickle cell disease, a genetic blood disorder that affects 70,000 to 80,000 people in the U.S., including about 1 in 500 people of African descent.
A clinical trial began enrolling participants testing a therapy for sickle cell disease to improve the flow of blood cells and relieve the pain that results.
4
Add a comment...

Alan Kotok

Shared publicly  - 
 
Catabasis Pharmaceuticals Inc., a biotechnology company creating treatments for rare diseases and cholesterol-related disorders, is raising $60 million in its initial public stock offering, trading on the Nasdaq exchange under the symbol CATB. #Science #Business
Catabasis Pharmaceuticals Inc., creating treatments for rare diseases and cholesterol-related disorders, is raising $60 million in its initial public offering.
2
1
Leah Shell's profile photo
Add a comment...

Alan Kotok
moderator

Cancer  - 
 
Special eyeglasses that adjust circadian rhythms of people with sleep disorders are being tested as a treatment for lung cancer patients with chronic insomnia. #Science #Technology #Health
Special eyeglasses that adjust circadian rhythms of people with sleep disorders are being tested as a treatment for lung cancer patients with chronic insomnia.
10
2
Isabel Balbina Etchepare's profile photoabak hoben's profile photo
Add a comment...
People
In his circles
4,914 people
Have him in circles
9,069 people
Chris J's profile photo
Ayoub Gnouma's profile photo
Scott Noble's profile photo
Amanda Cole's profile photo
Jamie Fisk's profile photo
Richard Green's profile photo
Ed Wiebe's profile photo
Ravi Pathak's profile photo
The Free USA - Tea Party Movement's profile photo
Education
  • Boston University
    MSc, Public Communications, 1967 - 1969
  • University of Iowa
    Journalism, 1963 - 1967
Basic Information
Gender
Male
Story
Tagline
Writer, editor, publisher, photographer, and runner ... in no particular order
Introduction
Alan Kotok is a Washington, DC-based reporter and writer on technology, business, and public policy, and editor and publisher of Science & Enterprise, an online news service on the value chain connecting scientific discovery with the marketplace. 
Bragging rights
Wrote three print and two e-books books, started two companies, ran two marathons
Work
Occupation
Officially retired, but working at what I like
Employment
  • Science magazine
    Managing editor, Science Careers, 2003 - 2010
Places
Map of the places this user has livedMap of the places this user has livedMap of the places this user has lived
Currently
Arlington, Va.